Humira Biosimilar Unlikely to Reach the Market Before 2020
The numerous biosimilars for AbbVie’s (NYSE:ABBV) Humira (adalimumab) are unlikely to reach the market prior to Amgen’s...
Humira Biosimilar Unlikely to Reach the Market Before 2020
Politicizing Science
ISSUE 12
In Memory of Dr. Sammy Lee, WKMJ's First Inspirational Healthcare Leader
Female Urinary Incontinence & Kegel Exercise with Biofeedback
Mark Paxton, Chief Executive Officer at RX-360
Issue12
Issue11
Dr. Augustine M.K. Choi, Chairman of the Department of Medicine
Issue11